Paper42515751
AI-Assisted Pharmaceutical Formulation Design: Comparative Development and Experimental Evaluation of Sustained-Release Lornoxicam Tablets.
Abdulkarim M and 8 others. Pharmaceuticals (Basel), 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. AI-Assisted Pharmaceutical Formulation Design: Comparative Development and Experimental Evaluation of Sustained-Release Lornoxicam Tablets. Papers, record 42515751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42515751
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- AI-Assisted Pharmaceutical Formulation Design: Comparative Development and Experimental Evaluation of Sustained-Release Lornoxicam Tablets.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Alfaisal University internal research grant (IRG 23522) | Alfaisal University | PubMed |
Source PubMed
References32
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31320117 | Advancing Drug Discovery via Artificial Intelligence. | Trends Pharmacol Sci | 2019 | https://conductscience.org/library/papers/31320117 | PubMed |
| 2 | 9188051 | Methods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tablets. | J Pharm Sci | 1997 | https://conductscience.org/library/papers/9188051 | PubMed |
| 3 | 11694007 | Powder mixing. | Drug Dev Ind Pharm | 2001 | https://conductscience.org/library/papers/11694007 | PubMed |
| 4 | 35631868 | Preparation and Characterization of Hydrophilic Polymer Based Sustained-Release Matrix Tablets of a High Dose Hydrophobic Drug. | Polymers (Basel) | 2022 | https://conductscience.org/library/papers/35631868 | PubMed |
| 5 | 19015997 | Controlled release hydrophilic matrix tablet formulations of isoniazid: design and in vitro studies. | AAPS PharmSciTech | 2008 | https://conductscience.org/library/papers/19015997 | PubMed |
| 6 | 21497624 | Critical factors in the release of drugs from sustained release hydrophilic matrices. | J Control Release | 2011 | https://conductscience.org/library/papers/21497624 | PubMed |
| 7 | 24381599 | The Effects of Lactose, Microcrystalline Cellulose and Dicalcium Phosphate on Swelling and Erosion of Compressed HPMC Matrix Tablets: Texture Analyzer. | Iran J Pharm Res | 2010 | https://conductscience.org/library/papers/24381599 | PubMed |
| 8 | 35132242 | AI in small-molecule drug discovery: a coming wave? | Nat Rev Drug Discov | 2022 | https://conductscience.org/library/papers/35132242 | PubMed |
| 9 | 23897035 | The effect of lubricants on powder flowability for pharmaceutical application. | AAPS PharmSciTech | 2013 | https://conductscience.org/library/papers/23897035 | PubMed |
| 10 | 34805969 | Tablet formulation development focusing on the functional behaviour of water uptake and swelling. | Int J Pharm X | 2021 | https://conductscience.org/library/papers/34805969 | PubMed |
| 11 | 31801986 | Rethinking drug design in the artificial intelligence era. | Nat Rev Drug Discov | 2020 | https://conductscience.org/library/papers/31801986 | PubMed |
| 12 | 23678458 | The role of oral controlled release matrix tablets in drug delivery systems. | Bioimpacts | 2012 | https://conductscience.org/library/papers/23678458 | PubMed |
| 13 | 37514102 | Artificial Intelligence in Pharmaceutical Technology and Drug Delivery Design. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/37514102 | PubMed |
| 14 | 14088963 | MECHANISM OF SUSTAINED-ACTION MEDICATION. THEORETICAL ANALYSIS OF RATE OF RELEASE OF SOLID DRUGS DISPERSED IN SOLID MATRICES. | J Pharm Sci | 1963 | https://conductscience.org/library/papers/14088963 | PubMed |
| 15 | 11369079 | Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). | Adv Drug Deliv Rev | 2001 | https://conductscience.org/library/papers/11369079 | PubMed |
| 16 | 25356469 | 1. Commentary on an exponential model for the analysis of drug delivery: Original research article: a simple equation for description of solute release: I II. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs, 1987. | J Control Release | 2014 | https://conductscience.org/library/papers/25356469 | PubMed |
| 17 | 26428517 | Dissolution Similarity Requirements: How Similar or Dissimilar Are the Global Regulatory Expectations? | AAPS J | 2016 | https://conductscience.org/library/papers/26428517 | PubMed |
| 18 | 30976107 | Applications of machine learning in drug discovery and development. | Nat Rev Drug Discov | 2019 | https://conductscience.org/library/papers/30976107 | PubMed |
| 19 | 33099022 | Artificial intelligence in drug discovery and development. | Drug Discov Today | 2021 | https://conductscience.org/library/papers/33099022 | PubMed |
| 20 | 31626923 | Prediction of tablet weight variability in continuous manufacturing. | Int J Pharm | 2020 | https://conductscience.org/library/papers/31626923 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42515751
GET https://conductscience.org/api/papers/v1/42515751/references?page=2